ArticleTissue engineering. Part A2021

Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent Arthrofibrosis.

Andy J Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.